Your session is about to expire
← Back to Search
Peer Genetic Coaching for Prostate Cancer
N/A
Waitlist Available
Led By Amy Leader, DrPh, MPH
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
Study Summary
This trial evaluates if a network of peer genetic coaches can help African American men with prostate cancer get genetic testing they may be unaware of, afford, or feel reluctant to seek due to mistrust.
Who is the study for?
This trial is for African American men over 18 with metastatic prostate cancer or high-risk features, and those with a strong family history of certain cancers. Participants must be comfortable reading and speaking English. It excludes minors, individuals who struggle to understand consent, or have significant anxiety during the consent process.Check my eligibility
What is being tested?
The study tests if peer genetic coaches can help overcome disparities in genetic testing among African American men with advanced prostate cancer by providing education, training, discussions, and navigation services to increase their engagement in genetic testing.See study design
What are the potential side effects?
Since this intervention involves educational activities rather than medical treatments or drugs, traditional physical side effects are not expected. However, participants may experience emotional distress or anxiety related to learning about genetic risks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number and percent of men making genetic counseling appointments
Number of inquiries to the central number (feasibility)
Percent of callers screened and eligible to participate (feasibility)
+2 moreSecondary outcome measures
Change in acceptability/attitude toward genetic counseling and testing
Change in decisional conflict for genetic counseling
Change of genetics knowledge
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive care (training, education, discussion)Experimental Treatment3 Interventions
AIM 1: Peer genetic coaches undergo training and education on study.
AIM 2: Patients receive an educational booklet and attend a discussion with a peer genetic coach on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~130
Find a Location
Who is running the clinical trial?
Thomas Jefferson UniversityLead Sponsor
445 Previous Clinical Trials
145,409 Total Patients Enrolled
7 Trials studying Prostate Cancer
1,526 Patients Enrolled for Prostate Cancer
Amy Leader, DrPh, MPHPrincipal InvestigatorThomas Jefferson University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am 18 years old or older.I am a man with advanced prostate cancer or have a strong family history of certain cancers.I am a man with prostate cancer experience and have undergone genetic counseling or testing. I also have experience in peer education or navigation.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive care (training, education, discussion)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the FDA endorse Supportive care (training, education, discussion) as a viable treatment option?
"Considering the limited data regarding its efficacy and safety, our team has assigned Supportive care (training, education, discussion) a score of 1 on an established scale."
Answered by AI
Is there availability for individuals to join the trial?
"According to clinicaltrials.gov, this experiment is currently not recruiting participants despite its initial posting on November 1st 2022 and subsequent edits two weeks later. However, 1259 other medical trials are actively searching for patients at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger